Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126152351 | 12615235 | 1 | I | 20160725 | 20160802 | 20160802 | EXP | IL-MYLANLABS-2016M1031428 | MYLAN | MASHIAH J, HAREL A, BITTERMAN O, SAGI L, GAT A, FELLIG Y, ET AL. ISOTRETINOIN TREATMENT OF AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS COMPLICATED BY COEXISTING DYSFERLINOPATHY. CLIN-EXP-DERMATOL 2016;41(4):390-393. | 0.00 | Y | 0.00000 | 20160802 | OT | IL | IL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126152351 | 12615235 | 1 | PS | ISOTRETINOIN | ISOTRETINOIN | 1 | Unknown | 40MG DAILY | U | 75945 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126152351 | 12615235 | 1 | Ichthyosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126152351 | 12615235 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126152351 | 12615235 | Blood creatine phosphokinase increased | |
126152351 | 12615235 | Unmasking of previously unidentified disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |